Author

Lorenz M. Jost

Observed names: Jost, Lorenz, L M Jost, L. Jost, Lorenz Jost

Observed institutions: University of Bern, European Organisation for Research and Treatment of Cancer, University of Pittsburgh, University of Basel, University of Zurich, European Society for Medical Oncology, University Hospital of Bern, Kantonsspital Baselland, University Hospital Zurich, European Organisation for Research and Treatment of Cancer, UPMC Hillman Cancer Center, Swiss Group For Clinical Cancer Research, Kantonsspital Baselland Standort Bruderholz

OpenAlex ID: A5113785262

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

2016 · Christian Dittrich, Michael Kosty, et al. · ESMO Open · 129

PDF

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial

2009 · Roger Stupp, Michael Mayer, et al. · The Lancet Oncology · 123

Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

2008 · P.G. Casali, L. Jost, et al. · Annals of Oncology · 114

PDF

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

2014 · P.G. Casali, P.G. Casali, et al. · Annals of Oncology · 111

PDF

Metabolism and Disposition of Vatalanib (PTK787/ZK-222584) in Cancer Patients

2006 · Lorenz M. Jost, Hans-Peter Gschwind, et al. · Drug Metabolism and Disposition · 76

Distinct Phenotypic and Functional Characteristics of Human Natural Killer Cells Obtained by Rapid Interleukin 2-Induced Adherence to Plastic

1993 · Nikola L. Vujanovic, Hannah Rabinowich, et al. · Cellular Immunology · 72

Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

2008 · S. Bielack, D. Carrle, et al. · Annals of Oncology · 62

PDF

Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study

2014 · Benjamin Kasenda, Annatina Bass, et al. · BMC Cancer · 56

PDF

Tumor-infiltrating lymphocytes

1992 · Theresa L. Whiteside, Lorenz M. Jost, et al. · Critical Reviews in Oncology/Hematology · 49

Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

2008 · R. Dummer, A. Hauschild, et al. · Annals of Oncology · 38

Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

2008 · M. Paulussen, S. Bielack, et al. · Annals of Oncology · 31

Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients – evaluation of outcome and prognostic factors: A retrospective multicenter study

2021 · Julia Fuchs, Martin Früh, et al. · PLoS ONE · 29

PDF

HIV-associated non-Hodgkin‚s lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy

1999 · J. Evison, J. Jost, et al. · AIDS · 29

Differentiated thyroid cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

2008 · F. Pacini, M.G. Castagna, et al. · Annals of Oncology · 22

Management of cancer pain: ESMO Clinical Recommendations

2008 · L. Jost, F. Roila · Annals of Oncology · 22

PDF

ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016

2016 · C. Dittrich, M. Kosty, et al. · Annals of Oncology · 19

PDF

Intra-Abdominal Nocardiosis—Case Report and Review of the Literature

2020 · Lucas Tramèr, Kirsten D. Mertz, et al. · Journal of Clinical Medicine · 17

PDF

Disposition and metabolism of LY2603618, a Chk-1 inhibitor following intravenous administration in patients with advanced and/or metastatic solid tumors

2014 · Enaksha R. Wickremsinhe, Scott M. Hynes, et al. · Xenobiotica · 11

Psoas Abscess Due to Mycobacterium avium in a Patient with Chronic Lymphocytic Leukemia—Case Report and Review

2019 · Natascha D. Diaco, Bettina Strohdach, et al. · Journal of Clinical Medicine · 10

PDF

Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

2007 · L. Jost · Annals of Oncology · 8

PDF

Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer

2023 · Jens Huober, Patrik Weder, et al. · JAMA Oncology · 7

A prospective study of risk‐adapted therapy for large cell non‐Hodgkin's lymphoma with VACOP‐B followed by high‐dose CBV and autologous progenitor cell transplantation for high‐risk patients in remission

1999 · Rolf A. Stahel, Lorenz M. Jost, et al. · British Journal of Haematology · 7

PDF

Y90‐Ibritumomab tiuxetan (Y90‐IT) and high‐dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05)

2016 · Michèle Voegeli, Stephanie Rondeau, et al. · Hematological Oncology · 5

Relapsed large B-cell non-Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

2007 · L. Jost · Annals of Oncology · 4

PDF

[High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].

2000 · L M Jost, H P Honegger, et al. · PubMed · 3

Works count: 41

Citation count: 1,060

H-index: 17

I10-index: 19